Tin tức & Cập nhật
Xem bài viết Nội tiết
Xem
Chỉ hiển thị Multimedia
Naltrexone–bupropion a safe weight-loss treatment for persons with obesity, depression
08 May 2026
bởiStephen Padilla
The extended-release combination of naltrexone and bupropion (NB-ER) may be used as safe and effective treatment for weight reduction among individuals with overweight/obesity and mild to moderate symptoms of depression, suggests a study.
Naltrexone–bupropion a safe weight-loss treatment for persons with obesity, depression
08 May 2026
Brolucizumab a viable alternative in proliferative diabetic retinopathy
02 May 2026
bởiJairia Dela Cruz
In the treatment of patients with proliferative diabetic retinopathy, brolucizumab outperforms panretinal laser photocoagulation in terms of preserving visual acuity, according to the international phase III CONDOR trial.